- Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors
Yosuke Miura et al, 2017, Oncology Letters CrossRef - Candidate biomarkers predictive of anthracycline and taxane efficacy against breast cancer
Shoko Norimura et al, 2018, Journal of Cancer Research and Therapeutics CrossRef - Expression of ERCC1, TYMS, TUBB3, RRM1 and TOP2A in patients with esophageal squamous cell carcinoma: A hierarchical clustering analysis
YONGKANG YU et al, 2014, Experimental and Therapeutic Medicine CrossRef - Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
Marianna Macerelli et al, 2016, Cancer Treatment Reviews CrossRef - Use of TUBB3 for Patient Stratification and Prognosis in Lung Cancer
Jan Nyrop Jakobsen et al, 2015, Lung Cancer Management CrossRef - The Prognostic Role of the Class III β-Tubulin in Non-Small Cell Lung Cancer (NSCLC) Patients Receiving the Taxane/Vinorebine-Based Chemotherapy: A Meta-Analysis
Yan-Long Yang et al, 2014, PLoS ONE CrossRef